A detailed history of Kennebec Savings Bank transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Kennebec Savings Bank holds 59 shares of CRL stock, worth $9,720. This represents 0.01% of its overall portfolio holdings.

Number of Shares
59
Holding current value
$9,720
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

BUY
$178.58 - $220.69 $10,536 - $13,020
59 New
59 $11.2 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.38B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Kennebec Savings Bank Portfolio

Follow Kennebec Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennebec Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Kennebec Savings Bank with notifications on news.